Persistent sexual side effects after SSRI discontinuation

Psychother Psychosom. 2006;75(3):187-8. doi: 10.1159/000091777.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Androgens / administration & dosage
  • Anxiety / drug therapy
  • Bupropion / administration & dosage
  • Cabergoline
  • Citalopram / adverse effects
  • Depressive Disorder / drug therapy
  • Dopamine Agonists / administration & dosage
  • Dopamine Uptake Inhibitors / administration & dosage
  • Ergolines / administration & dosage
  • Female
  • Fluoxetine / adverse effects
  • Humans
  • Male
  • Monoamine Oxidase Inhibitors / administration & dosage
  • Piperazines / administration & dosage
  • Plants, Medicinal
  • Purines
  • Selective Serotonin Reuptake Inhibitors / adverse effects*
  • Selegiline / administration & dosage
  • Sertraline / adverse effects
  • Sexual Dysfunctions, Psychological / chemically induced*
  • Sexual Dysfunctions, Psychological / drug therapy
  • Sildenafil Citrate
  • Sleep Initiation and Maintenance Disorders / drug therapy
  • Sulfones
  • Testosterone / administration & dosage
  • Time Factors
  • Treatment Outcome
  • Vasodilator Agents / administration & dosage

Substances

  • Androgens
  • Dopamine Agonists
  • Dopamine Uptake Inhibitors
  • Ergolines
  • Monoamine Oxidase Inhibitors
  • Piperazines
  • Purines
  • Serotonin Uptake Inhibitors
  • Sulfones
  • Vasodilator Agents
  • Fluoxetine
  • Bupropion
  • Citalopram
  • Selegiline
  • Testosterone
  • Sildenafil Citrate
  • Cabergoline
  • Sertraline